CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $96,431
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Durso Jerome Benedict President and CEO | Purchase | +30,700 | $1.62 | $50K | 93,200 |
| 2026-08-13 | Durso Jerome Benedict President and CEO | Purchase | +15,000 | $2.95 | $44K | 62,500 |
| 2026-04-01 | Durso Jerome Benedict President and CEO | Purchase | +15,000 | $3.14 | $47K | 47,500 |
| 2026-03-06 | Durso Jerome Benedict President and CEO | Purchase | +20,000 | $3.54 | $71K | 32,500 |
| 2025-12-22 | Durso Jerome Benedict Director | Purchase | +12,500 | $4.13 | $52K | 12,500 |
| 2025-12-01 | Durso Jerome Benedict CEO-elect | Grant or award · Stock Options (option to buy) | +1,824,400 | 1,824,400 | ||
| 2025-12-01 | Durso Jerome Benedict CEO-elect | Grant or award · Restricted Stock Units | +633,700 | 633,700 | ||
| 2025-09-25 | Durso Jerome Benedict Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-02-24 | Durso Jerome Benedict Director | Grant or award · Stock Options (option to buy) | +69,800 | 69,800 |
Page 1 of 1 · 9 trades